From: circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer
Parameter | No. of patients | circLMTK2 (high) | circLMTK2 (low) | P -value |
---|---|---|---|---|
Sex | Â | Â | Â | 0.871 |
 male | 67 | 35 | 32 |  |
 female | 53 | 26 | 27 |  |
Age (year) | Â | Â | Â | 0.965 |
  < 60 | 46 | 24 | 22 |  |
  ≥ 60 | 74 | 37 | 37 |  |
Tumor site | Â | Â | Â | 0.681 |
 Upper | 26 | 12 | 14 |  |
 Middle | 35 | 17 | 18 |  |
 Lower | 47 | 24 | 23 |  |
 Diffuse | 12 | 8 | 4 |  |
Tumor size (cm) | Â | Â | Â | 0.279 |
  < 5 | 54 | 24 | 30 |  |
  ≥ 5 | 66 | 37 | 29 |  |
Differentiation grade | Â | Â | Â | 0.734 |
 Well-moderate | 50 | 24 | 26 |  |
 Poor-undifferentiation | 70 | 37 | 33 |  |
Lauren classification | Â | Â | Â | 0.812 |
 Intestinal | 58 | 29 | 29 |  |
 Diffuse | 37 | 20 | 17 |  |
 Mixed | 20 | 9 | 11 |  |
 Uncertain | 5 | 3 | 2 |  |
T stage | Â | Â | Â | 0.017* |
 T1-T3 | 65 | 26 | 39 |  |
 T4 | 55 | 35 | 20 |  |
Lymph node status | Â | Â | Â | 0.029* |
 Negative | 56 | 22 | 34 |  |
 Positive | 64 | 39 | 25 |  |
Distant metastasis | Â | Â | Â | 0.227 |
 M0 | 109 | 53 | 56 |  |
 M1 | 11 | 8 | 3 |  |
TNM stage | Â | Â | Â | 0.004* |
 I-II | 56 | 20 | 36 |  |
 III-IV | 64 | 41 | 23 |  |
Lymphatic invasion | Â | Â | Â | 0.446 |
 Negative | 51 | 29 | 22 |  |
 Positive | 69 | 32 | 37 |  |
Nervous invasion | Â | Â | Â | 0.694 |
 Negative | 52 | 28 | 24 |  |
 Positive | 68 | 33 | 35 |  |